NCT02002156 - A Study of the Interaction Between BCG And MenC Immunisation: BAM | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

June 27, 2018

Conditions

BCG InfectionReaction - VaccineImmune Response

Interventions

BIOLOGICAL

BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®

This group will receive BCG at birth and all routine vaccinations.

BIOLOGICAL

BCG, NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®

This group will receive BCG at three months old and all routine vaccinations.

BIOLOGICAL

NeisVac-C®, Pediacel®, Infanrix™, Prevenar-13®, Menitorix®, Priorix®, Rotarix®

This group will receive no BCG but will receive all routine vaccinations.

Trial Locations (1)

University of Oxford, Oxford Vaccine Group, Oxford

All Listed Sponsors

lead

University of Oxford

OTHER